Clinical studies recruiting near Aalst

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · AZORG Campus Aalst-Moorselbaan · Pfizer · NCT07028853 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · AZORG Ziekenhuis · Boehringer Ingelheim · NCT07355296 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · AZORG Campus Aalst-Moorselbaan · Hoffmann-La Roche · NCT06793215 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Azorg Campus Aalst - Moorselbaan · Amgen · NCT07037433 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Azorg · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Effect of IMT in Patients After Acute Exacerbations of COPD
NA · AZORG · KU Leuven · NCT07213128 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · AZORG Campus Aalst-Moorselbaan · Eli Lilly and Company · NCT06937086 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · AZORG Campus Aalst-Moorselbaan ( Site 0604) · Merck Sharp & Dohme LLC · NCT06077760 OPTION-EMEA Clinical Trial
NA · AZORG - Hospital · Boston Scientific Corporation · NCT07349121 HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
Phase 2 · OLV Aalst · Abscint NV/SA · NCT06369831 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · AZORG Ziekenhuis · Boehringer Ingelheim · NCT07220083 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · AZORG campus Aalst Moorselbaan · Janssen Research & Development, LLC · NCT06319820 Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations
NA · AZorg · University Hospital, Ghent · NCT07402057 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414 Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
Phase 4 · OLV Aalst · Universitaire Ziekenhuizen KU Leuven · NCT05169593 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
Phase 4 · AZORG · Ziekenhuis Oost-Limburg · NCT07359599 Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With
Phase 4 · OLV Aalst · Universitaire Ziekenhuizen KU Leuven · NCT06003283 Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Phase 3 · AZORG · Universitaire Ziekenhuizen KU Leuven · NCT05569772 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · AZORG Campus Aalst-Moorselbaan · Eli Lilly and Company · NCT06937099 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary
Phase 2 · Site 3101 - AZORG - Aalst · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis P · NCT05128825 Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 202
Phase N/A · Onze Lieve Vrouw Ziekenhuis · European Organisation for Research and Treatment of Cancer - · NCT05259605 A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocar
Phase N/A · OLV Hospital Aalst · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT05993234 Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
NA · AZorg Aalst · Arga Medtech SA · NCT06784466 Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases
NA · AZORG · Cancer Research Antwerp · NCT07146074 Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
NA · OLVZ Aalst · Cancer Research Antwerp · NCT06613295 Abbott Vascular Medical Device Registry
Phase N/A · Onze-Lieve-Vrouwziekenhuis Campus Aalst · Abbott Medical Devices · NCT04573660 A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06567782

Look up another city

Look up another condition